Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in active and latent tuberculosis
- 20 November 2008
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 28 (6) , 667-670
- https://doi.org/10.1007/s10096-008-0670-8
Abstract
The objective was to compare the quantitative T-cell responses measured by the commercial interferon-gamma (IFNγ) release assays (IGRAs) in active and latent tuberculosis (TB) states. T-cell responses of culture-proven TB cases were compared with those of contacts with positive IGRA results and tuberculin skin tests ≥ 15 mm. T-SPOT.TB results in 270 active TB cases and 183 community contacts showed the median spot-forming cells (SFCs) above negative control/2.5 × 105 peripheral blood mononuclear cells to be 27 (−1 to 203) vs 10 (−2 to 174) in response to ESAT-6 (p < 0.001); and 37 (0 to 293) vs 13 (0 to 225) to CFP-10 (p < 0.001). The median IFNγ levels (antigen minus nil control) as measured by QuantiFERON-TB Gold In-tube in 270 cases and 142 contacts in congregate settings was 2.3 IU/ml (−0.58 to 31.44) vs 1.7 IU/ml (0.35 to 26.51, p = 0.98). Quantitative T-cell responses as measured by the T-SPOT.TB may indicate mycobacterial burden and disease activity, but cannot be used to discriminate active from latent TB.Keywords
This publication has 14 references indexed in Scilit:
- Diagnosing Tuberculosis Infection in the 21st CenturyChest, 2007
- Sensitivity of a Whole-Blood Interferon-Gamma Assay Among Patients with Pulmonary Tuberculosis and Variations in T-Cell Responses During Anti-Tuberculosis TreatmentInfection, 2007
- Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for ResearchAnnals of Internal Medicine, 2007
- Latent Tuberculosis Infection Treatment and T-Cell Responses to Mycobacterium tuberculosis–specific AntigensAmerican Journal of Respiratory and Critical Care Medicine, 2007
- New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosisExpert Review of Molecular Diagnostics, 2006
- Reversion of the ELISPOT test after treatment in Gambian tuberculosis casesBMC Infectious Diseases, 2006
- Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.2005
- Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test.2005
- Treatment of latent TB infection for close contacts as a complementary TB control strategy in Singapore.2004
- Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreakThe Lancet, 2003